• Home
  • Research
  • SURGICAL OUTCOMES OF TRANSDUODENAL AMPULLECTOMY FOR EARLY CANCER OF THE AMPULLA OF VATER: A SINGLE-CENTER STUDY
Bài báo nghiên cứu gốc

SURGICAL OUTCOMES OF TRANSDUODENAL AMPULLECTOMY FOR EARLY CANCER OF THE AMPULLA OF VATER: A SINGLE-CENTER STUDY

https://doi.org/10.70755/vnjo.2025.78.17

.

Abstract

Background: Transduodenal ampullectomy (TDA) is performed for early cancer of the ampulla of Vater (AoV). This study aimed to analyze the short- and long-term outcomes of TDA.

Methods: Patients who underwent TDA performed for AoV malignancy with carcinoma in-situ (Tis) and T1 stage from August 2017 to February 2025 were reviewed.

Results: Twenty-eight patients with malignant tumors underwent TDA. The mean operation time was 118.6 ± 36.8 min. The median estimated blood loss was 60 (0-700)ml. The median length of hospital stays was 9 (6-22) days. The mean overall complication rate was 14.3 % with postoperative pancreatic fistula was 17.9%. Lymph node metastasis rates were 20%. The overall survival (OS) and disease-free survival (DFS) rate were 52.4 and 51.2 months, respectively.

Conclusion: TDA accompanied with lymph node dissection was advisable in Tis and T1 AoV cancers in view of superior perioperative outcomes and similar long-term survival rates.

.

Keywords

transduodenal ampullectomy, ampulla of vater

1. Jorge Albores‐Saavedra, Arnold M Schwartz, Kristen Batich, et al (2009). Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. Journal of surgical oncology. 100 (7), 598-605.

2. Dirk J Gouma, Rutger CI van Geenen, Thomas M van Gulik, et al (2000). Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Annals of surgery. 232 (6), 786-795.

3. Joon Seong Park, Dong Sup Yoon, Kyung Sik Kim, et al (2007). Factors influencing recurrence after curative resection for ampulla of Vater carcinoma. Journal of surgical oncology. 95 (4), 286-290.

4. Marek Sierzega, Krystyna Nowak, Jan Kulig, et al (2009). Lymph node involvement in ampullary cancer: the importance of the number, ratio, and location of metastatic nodes. Journal of surgical oncology. 100 (1), 19-24.

5. Yoo-Seok Yoon, Sun-Whe Kim, Sang Jae Park, et al (2005). Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy. Annals of surgery. 242 (1), 92-100.

6. Yang Gao, Yayun Zhu, Xiuyan Huang, et al (2016). Transduodenal ampullectomy provides a less invasive technique to cure early ampullary cancer. BMC surgery. 16 1-8.

7. Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien (2004). Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of surgery. 240 (2), 205-213.

8. Claudio Bassi, Giovanni Marchegiani, Christos Dervenis, et al (2017). The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. surgery. 161 (3), 584-591.

9. Fabio Francesco di Mola, Paolo Panaccio, Tommaso Grottola, et al (2021). Transduodenal surgical ampullectomy: a procedure that requires a multidisciplinary approach. Updates in Surgery. 1-9.

10. Darren L Scroggie, Vasileios K Mavroeidis (2021). Surgical ampullectomy: A comprehensive review. World Journal of Gastrointestinal Surgery. 13 (11), 1338.

11. Seung-Soo Hong, Sung-Sik Han, Wooil Kwon, et al (2021). Comparison of oncologic outcomes between transduodenal ampullectomy and pancreatoduodenectomy in ampulla of vater cancer: Korean multicenter study. Cancers. 13 (9), 2038.

12. Christian Heise, Einas Abou Ali, Dirk Hasenclever, et al (2020). Systematic review with meta-analysis: endoscopic and surgical resection for ampullary lesions. Journal of clinical medicine. 9 (11), 3622.

13. Eun-Ki Min, Seung Soo Hong, Ji Su Kim, et al (2022). Surgical outcomes and comparative analysis of transduodenal ampullectomy and pancreaticoduodenectomy: a single-center study. Annals of surgical oncology. 1-12.

Previous
REAL-WORLD DATA ON THE EFFICACY AND SAFETY OF PAZOPANIB AS FIRST-LINE TREATMENT FOR ADVANCED RENAL CELL CARCINOMA AT K HOSPITAL
Next
RESULTS OF SURGICAL TREATMENT OF MEDULLOBLASTOMAS AT VIETNAM NATIONAL CANCER HOSPITAL